AMPHASTAR PHARMACEUTICALS IN (AMPH) Stock Income Statement
NASDAQ:AMPH • US03209R1032
Current stock price
21.91 USD
-0.05 (-0.23%)
Last:
| 2025 (2025-12-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 719.89M | 731.97M | 644.39M | 499.00M | 437.80M | |||
| Minority Interest Expense | N/A | N/A | N/A | 0.00 | -1.20M | |||
| Cost Of Goods | 363.83M | 358.11M | 290.57M | 250.10M | 238.00M | |||
| Gross Profit | 356.06M | 373.86M | 353.82M | 248.90M | 199.70M | |||
| Operating Expenses | 215.65M | 168.44M | 154.13M | 141.40M | 129.90M | |||
| Research and Development | 71.24M | 61.43M | 63.89M | 64.70M | 49.90M | |||
| Selling, General, and Administrative Expenses | 129.81M | 94.52M | 80.39M | 66.60M | 68.90M | |||
| Operating Income | 140.40M | 205.42M | 199.69M | 107.50M | 69.90M | |||
| Interest Income/Expense | -16.80M | -19.73M | -18.70M | -500.00K | -300.00K | |||
| Other Income/Expense | 23.00K | 4.08M | -3.93M | 14.50M | 900.00K | |||
| Non Recurring Items | N/A | N/A | -5.70M | -5.40M | 13.60M | |||
| Income Before Taxes | 123.62M | 189.76M | 171.36M | 116.00M | 84.10M | |||
| Income Tax | 25.53M | 29.67M | 31.83M | 23.50M | 20.60M | |||
| Net Income | 98.09M | 159.52M | 137.54M | 91.40M | 62.10M | |||
| EBITDA | 197.10M | 258.39M | 237.72M | 132.74M | 93.39M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | 2.03 | 3.06 | 2.60 | 1.74 | 1.25 | |||
| Non GAAP EPS | 3.25 | 3.86 | 3.30 | 1.97 | 1.36 | |||
| Statistics | ||||||||
| Gross Profit Margin | 49.46% | 51.08% | 54.91% | 49.88% | 45.61% | |||
| Profit Margin | 13.63% | 21.79% | 21.34% | 18.32% | 14.18% | |||
| Operating Profit Margin | 19.50% | 28.06% | 30.99% | 21.54% | 15.97% | |||
All data in USD